Eczacibasi Ilac Sanayi ve T.A.S. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eczacibasi Ilac Sanayi ve T.A.S. with three other
pharmaceutical manufacturers in Europe:
of the United Kingdom
sales of £144.03 million [US$177.16 million]
of which 100%
was Antibodies & Related Products),
Mph Mittelstaendische Pharma Holding AG
(262.89 million Euro [US$288.57 million]
Laboratorios Farmaceuticos Rovi S.A.
based in Spain
(246.01 million Euro [US$270.04 million]
of which 82%
Eczacibasi Ilac Sanayi ve T.A.S. reported sales of 1.17 billion Turkish Liras (US$378.17 million)
December of 2015.
increase of 11.8%
versus 2014, when the company's sales were 1.05 billion Turkish Liras.
Sales of Health saw an increase
that was more than double the company's growth rate: sales were up
43.3% in 2015, from
165.50 million Turkish Liras to 237.09 million Turkish Liras.
Not all segments of Eczacibasi Ilac Sanayi ve T.A.S. experienced an increase in sales in 2015:
sales of Real Estate Development fell 47.6% to 94.16 million Turkish Liras.